Back to Companies
Xilio Therapeutics, Inc.
XLONasdaqCIK: 0001840233
Recent Form 4 activity at Xilio Therapeutics, Inc. (XLO) spans 14 filings across 10 insiders (all of them on the buy side). Purchases total $44.0K against $0 in sales — heavily weighted toward buying, for a net purchase of $44.0K. Houvras Yariv is the most active by dollar volume, and the single largest transaction was $935.5K by Houvras Yariv. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$1.3M
Purchases
$44.0K
Sales
$0
Unique Insiders
10
Recent Insider Trades
14 loaded
| Oct 2 | XLO Xilio Therapeutics, Inc. | Houvras Yariv | Insider | Award | $935.5K |
| Oct 2 | XLO Xilio Therapeutics, Inc. | Houvras Yariv | Insider | Other | $0 |
| Jun 12 | XLO Xilio Therapeutics, Inc. | Curran Daniel J. | Insider | Award | $40.0K |
| Jun 12 | XLO Xilio Therapeutics, Inc. | Shannon James Samuel | Insider | Award | $40.0K |
| Jun 12 | XLO Xilio Therapeutics, Inc. | Xu Yuan | Insider | Award | $40.0K |
| Jun 12 | XLO Xilio Therapeutics, Inc. | Bello Akintunde Olatokumbo | Insider | Award | $40.0K |
| Jun 12 | XLO Xilio Therapeutics, Inc. | Bonstein Sara | Insider | Award | $40.0K |
| Jun 12 | XLO Xilio Therapeutics, Inc. | ROSS ROBERT W. | Insider | Award | $40.0K |
| Jun 12 | XLO Xilio Therapeutics, Inc. | Brennan Aoife | Insider | Award | $40.0K |
| Apr 16 | XLO Xilio Therapeutics, Inc. | Blanchard Cheryl R | Insider | Other | $0 |
| Apr 16 | XLO Xilio Therapeutics, Inc. | Blanchard Cheryl R | Insider | Award | $84.0K |
| Mar 30 | XLO Xilio Therapeutics, Inc. | Shannon James Samuel | Insider | Buy | $44.0K |
| Feb 17 | XLO Xilio Therapeutics, Inc. | GILEAD SCIENCES, INC. | 10% Owner | Other | $374 |
| Dec 1 | XLO Xilio Therapeutics, Inc. | GILEAD SCIENCES, INC. | 10% Owner | Exercise | $1.3K |
14 filings